AP4S1
Basic information
Region (hg38): 14:31025106-31130996
Links
Phenotypes
GenCC
Source:
- hereditary spastic paraplegia 52 (Strong), mode of inheritance: AR
- hereditary spastic paraplegia 52 (Strong), mode of inheritance: AR
- AP4-related intellectual disability and spastic paraplegia (Supportive), mode of inheritance: AR
- AP-4 deficiency syndrome (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spastic paraplegia 52, autosomal recessive | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Neurologic | 21620353 |
ClinVar
This is a list of variants' phenotypes submitted to
- Spastic paraplegia (8 variants)
- not provided (3 variants)
- Inborn genetic diseases (2 variants)
- Spastic paraplegia 52, autosomal recessive (2 variants)
- Intellectual disability (1 variants)
- APS41-related disorder (1 variants)
- Neurodevelopmental disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AP4S1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 10 | 10 | ||||
missense | 23 | 26 | ||||
nonsense | 5 | |||||
start loss | 1 | |||||
frameshift | 5 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 6 | |||||
splice region | 1 | 1 | 1 | 3 | 6 | |
non coding | 50 | 36 | 23 | 109 | ||
Total | 8 | 9 | 74 | 47 | 24 |
Highest pathogenic variant AF is 0.0000329
Variants in AP4S1
This is a list of pathogenic ClinVar variants found in the AP4S1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
14-31025782-G-A | not specified | Benign (Apr 15, 2016) | ||
14-31025953-C-A | not specified | Uncertain significance (Sep 20, 2023) | ||
14-31025981-G-C | not specified | Uncertain significance (Oct 05, 2021) | ||
14-31026004-T-C | not specified | Uncertain significance (Sep 17, 2021) | ||
14-31026007-G-C | not specified | Uncertain significance (Aug 01, 2023) | ||
14-31026056-G-A | not specified | Uncertain significance (Jul 19, 2023) | ||
14-31026080-C-T | not specified | Uncertain significance (May 08, 2023) | ||
14-31026088-C-T | not specified | Uncertain significance (Mar 31, 2023) | ||
14-31026101-C-T | not specified | Likely benign (Apr 03, 2023) | ||
14-31065851-A-G | Benign (Jun 14, 2018) | |||
14-31065881-C-T | Likely benign (Aug 15, 2018) | |||
14-31065911-C-T | Benign (Jul 31, 2018) | |||
14-31066198-T-C | Inborn genetic diseases • Spastic paraplegia | Likely pathogenic (Apr 24, 2023) | ||
14-31066201-T-TA | Spastic paraplegia | Pathogenic (Nov 24, 2022) | ||
14-31066213-T-C | Inborn genetic diseases • Spastic paraplegia | Likely pathogenic (Jul 24, 2017) | ||
14-31066217-G-A | not specified | Uncertain significance (Jan 20, 2015) | ||
14-31066225-A-G | not specified • Spastic paraplegia • Spastic paraplegia 52, autosomal recessive • Hereditary spastic paraplegia | Conflicting classifications of pathogenicity (Jan 22, 2024) | ||
14-31066230-G-A | Spastic paraplegia | Uncertain significance (Jul 21, 2022) | ||
14-31066239-C-T | Spastic paraplegia • Spastic paraplegia 52, autosomal recessive | Pathogenic (Apr 22, 2024) | ||
14-31066240-G-A | Spastic paraplegia 52, autosomal recessive | Uncertain significance (Dec 15, 2022) | ||
14-31066242-C-CT | Spastic paraplegia | Likely pathogenic (Oct 01, 2020) | ||
14-31066263-G-A | Inborn genetic diseases | Uncertain significance (Feb 10, 2022) | ||
14-31066266-G-A | Spastic paraplegia | Uncertain significance (Dec 11, 2023) | ||
14-31066278-C-T | Spastic paraplegia | Uncertain significance (Aug 22, 2022) | ||
14-31066279-G-A | Spastic paraplegia • Spastic paraplegia 52, autosomal recessive | Uncertain significance (Oct 17, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AP4S1 | protein_coding | protein_coding | ENST00000216366 | 5 | 68507 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000173 | 0.257 | 125679 | 0 | 56 | 125735 | 0.000223 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0101 | 85 | 84.7 | 1.00 | 0.00000423 | 1054 |
Missense in Polyphen | 24 | 24.6 | 0.9756 | 321 | ||
Synonymous | -0.390 | 30 | 27.4 | 1.09 | 0.00000119 | 286 |
Loss of Function | 0.119 | 9 | 9.39 | 0.958 | 6.17e-7 | 93 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000437 | 0.000437 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000255 | 0.000255 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000229 | 0.000229 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the adaptor protein complex 4 (AP-4). Adaptor protein complexes are vesicle coat components involved both in vesicle formation and cargo selection. They control the vesicular transport of proteins in different trafficking pathways (PubMed:10066790, PubMed:10436028). AP-4 forms a non clathrin- associated coat on vesicles departing the trans-Golgi network (TGN) and may be involved in the targeting of proteins from the trans-Golgi network (TGN) to the endosomal-lysosomal system. It is also involved in protein sorting to the basolateral membrane in epithelial cells and the proper asymmetric localization of somatodendritic proteins in neurons. AP-4 is involved in the recognition and binding of tyrosine-based sorting signals found in the cytoplasmic part of cargos, but may also recognize other types of sorting signal (Probable). {ECO:0000269|PubMed:10066790, ECO:0000269|PubMed:10436028, ECO:0000305|PubMed:10066790, ECO:0000305|PubMed:10436028}.;
- Pathway
- Lysosome - Homo sapiens (human);Lysosome Vesicle Biogenesis;Clathrin derived vesicle budding;trans-Golgi Network Vesicle Budding;Vesicle-mediated transport;Membrane Trafficking
(Consensus)
Intolerance Scores
- loftool
- 0.382
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 28.63
Haploinsufficiency Scores
- pHI
- 0.164
- hipred
- N
- hipred_score
- 0.177
- ghis
- 0.637
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.982
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ap4s1
- Phenotype
Gene ontology
- Biological process
- protein targeting;protein localization
- Cellular component
- AP-4 adaptor complex;endosome lumen;trans-Golgi network membrane;intracellular membrane-bounded organelle
- Molecular function